** 🇮🇳 India Daybook: Tata Motors Profit Jumps 70%, Lupin Gets USFDA Nod

**

📍 EARNINGS

• Tata Motors: Reported a 69.55% jump in standalone net profit to ₹2,406 crore for Q4 FY26. Standalone revenue grew by 22.26% to ₹24,452 crore, supported by strong performance in the commercial vehicle segment.
• BHEL: The PSU major reported a massive rise in FY26 PAT to ₹1,578 crore, up from ₹513 crore in the previous fiscal, driven by improved execution and a robust order book.
• Oil India: Post-market results showed a 62% jump in Q4 PAT to ₹2,424 crore, marking its highest daily production in over a decade.
• NLC India: Reported a quarterly PAT of ₹2,525 crore and declared a final dividend of ₹0.25 per share.
• Paras Defence: Q4 net profit surged by 74% YoY, although the stock has seen some profit booking recently.
• Bharti Airtel: While net profit for the quarter slipped 26%, the company approved a major share swap deal to increase its stake in Airtel Africa.
• Cohance Lifesciences: Reported a weak Q4 with net profit declining 83.8% YoY to ₹0.2 billion.

📍 ORDER WIN

• Tata Motors: Secured its largest-ever export order for 70,000 Yodha and Ultra T.7 vehicles for Indonesia and won pan-India orders for over 5,000 buses from various State Transport Undertakings.
• Interarch Building Solutions: Bagged a significant domestic order worth ₹102 crore for the design, engineering, and erection of a pre-engineered steel building system.
• BHEL: Announced total order inflows of ₹75,000 crore for FY26, taking its total unexecuted order book to a record ₹2.4 lakh crore.

📍 ACQUISITION

• Black Box Ltd: Completed the acquisition of Brazil-based 2S Inovações Tecnológicas S.A. to expand its digital infrastructure and cybersecurity footprint in Latin America.

📍 REGULATORY / USFDA

• Lupin: Received USFDA approval for its Famotidine Injection USP (20 mg/2 mL), a generic version of Pepcid, indicated for hospitalized patients with hypersecretory conditions.
• Alembic Pharmaceuticals: Secured tentative approval from the USFDA for its Bosutinib Tablets (400 mg), used in treating chronic myeloid leukemia.

📍 DIVIDEND

• Bharti Airtel: Board recommended a dividend of ₹24 per equity share for the financial year.
• DLF Ltd: Declared a dividend of ₹8 per share for FY26.
• Ex-Dividend Today: Stocks including Oberoi Realty (₹2.00), Kewal Kiran Clothing (KKCL) (₹2.00), and NRB Bearings (₹2.25) will trade ex-dividend today.

📍 MACRO NEWS

• Currency: The Indian Rupee crashed to a new record low of 95.80 against the US Dollar, driven by persistent FII outflows and a surge in Brent crude prices to $107 per barrel.
• Commodities: Domestic gold prices soared by over ₹8,500 following a hike in import duties aimed at curbing the widening trade deficit.

TAGS: India Daybook, Stocks in News, Corporate News, Stock Market, Company News

Tags: ** India Daybook Stocks in News Corporate News Stock Market Company News